MDK and metastatic malignant neoplasm in the lymph nodes: When combined with squamous cell carcinoma antigen (SCCA), the current cervical cancer biomarker in use to predict lymph node metastasis and prognosis, the combination of SCCA and MDK had a higher AUC than either alone, indicating higher diagnostic accuracy [159].